Raleigh pharma raises $5M as phase 3 study begins
March 16, 2023 at 07:44 AM EDT
A Raleigh pharmaceutical company is raising money as it moves its lead drug into a late-stage study.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |